Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06533631 · ClinicalTrials.gov registry record
Measuring Brain Health Using Low-Field Portable MRI
A clinical trial of White Matter Hyperintensity, sponsored by Yale University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06533631: Recruiting study of White Matter Hyperintensity, sponsored by Yale University.
NCT06533631 is a study of White Matter Hyperintensity that is actively recruiting participants, run by Yale University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06533631, a study of White Matter Hyperintensity, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a new grading scale and utilize automated segmentation for measurement of White Matter Hyperintensity (WMH) volume using a low field MRI.
Primary Outcome
Each pMRI scan will be evaluated by two readers experienced in the adjudication of WMH and the high-field 3T MRI will be adjudicated by a board certified neuroradiologist. WMH will be graded on a low-field WMH scale as minimal, moderate, or severe. The low-field WMH scale will be derived by an expert panel consisting of the study investigators and two more neurologists, a neuroradiologist, and neuropsychologist. Investigators will employ the Delphi method to harness the collective expertise of t
Conditions Studied
Interventions
- DEVICE Portable low-field MRI (pMRI)
- DEVICE 3T MRI
Study Locations (1)
Connecticut
- Yale Magnetic Resonance Research Center (MRRC) at The Analyn Center (TAC) - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2026-11 |
What NCT06533631 shows while recruiting
NCT06533631 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with White Matter Hyperintensity appearing as the primary indexed condition, and to 2 interventions - of which Portable low-field MRI (pMRI) is the first listed.
NCT06533631 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06533631 about?
NCT06533631 is a clinical study titled "Measuring Brain Health Using Low-Field Portable MRI". The purpose of this study is to develop a new grading scale and utilize automated segmentation for measurement of White Matter Hyperintensity (WMH) volume using a low field MRI.
What is the current status of trial NCT06533631?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-02-05. Estimated completion is 2026-11.
What conditions does trial NCT06533631 study?
This clinical trial studies the following conditions: White Matter Hyperintensity.
What interventions are being tested in trial NCT06533631?
The interventions under investigation include: Portable low-field MRI (pMRI) (DEVICE), 3T MRI (DEVICE).
Who is sponsoring clinical trial NCT06533631?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06533631 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI